Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.46%
SPX
+0.50%
IXIC
+0.80%
FTSE
+0.52%
N225
+0.60%
AXJO
+0.90%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

AGEN has been granted a new patent

Sep 18, 2024, 10:37 PM
-24.71%
What does AGEN do
Agenus, a US-based biotechnology company headquartered in Lexington, specializes in immuno-oncology therapies targeting cancer and infectious diseases, employing 389 staff. Its pipeline includes advanced antibodies and various immunotherapy classes.
AGEN filed a patent for "t cell receptors that bind to mixed lineage leukemia (mll)-specific phosphopeptides and methods of use thereof" on Fri, June 23, 2023. The patent was officially published on Thu, September 12, 2024.
📡️ Health Care
Patents

More Signals

Feature in Progress
This section is under development. Check back soon for updates!